RadioNano Therapeutics Inc.
RadioNano Therapeutics株式会社
Ticker
—
Listed market
—
Country
Employees (non-consolidated)
—
Related companies
9
§01
Basic information
- Head office
- 36-1 Yoshida Honmachi, Sakyo-ku, Kyoto City, Kyoto Prefecture 606-8317
- Chief executive
- Masatoshi Chiba
- Capital
- 100,000,000
- Employees (non-consolidated)
- Employees (consolidated)
- Start date
- 2024-04-01
- End date
§02
Websites
§03
Business
Research and development of cancer therapeuticsDevelopment of therapies based on boron neutron capture therapy (BNCT)Development of radiopharmaceuticals using nanoparticles
§04
Related companies
| Company name | Group | Parent | Subsidiary | Customer | Supplier | Alliance | Bank | Shareholder |
|---|---|---|---|---|---|---|---|---|
|
|
||||||||
| RadioNano Therapeutics(ラジオナノセラピューティクス)株式会社 | ||||||||
|
|
||||||||
|
|
||||||||
|
|
||||||||
|
|
||||||||
|
|
||||||||
|
|
||||||||
|
|
Names without a link are companies not yet registered in OpenBizGraph
§05
Network
Drag to move · click to open
§06
History
[Lunch Seminar] At the 5th Annual Meeting of the Japan Society for Quantum Medical Science (2025/11/14), held from 14-15 November 2025 at Kyushu University, our company co-hosted a lunch seminar with TAE Life Sciences. Professor Komatsu from Kyoto University presented "From Molecules to Nanoparticles: The Paradigm Shift of BNCT," discussing the research path and results leading to the birth of RN-501, which received positive feedback.![]()
§07
News
There is no news.
§09
Sources & updates
DOMAINOwn domain:Yes
UPDATED2026-11-09 18:10 · Model: ggml-org/gpt-oss-20b